Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72722 record(s)

Req # A-2022-000459

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108879-949.

Organization: Health Canada

7 page(s)
September 2024

Req # A-2023-000723

Adverse Drug Reactions (ADRs). Report numbers: E2B_05649767, E2B_02763747, 000972665, E2B_05628398, E2B_06216442, E2B_06186458, E2B_03293332, E2B_06030016, 001034630, E2B_06264505.

Organization: Health Canada

1296 page(s)
September 2024

Req # A-2023-001039

Adverse Drug Reaction (ADR). Report number: E2B_06496077.

Organization: Health Canada

9 page(s)
September 2024

Req # A-2023-001309

Adverse Drug Reactions (ADRs). Report numbers: E2B_06451765, 1043220, E2B_06450183, 1050539, 1050563, 1052286, E2B_06566392, 1052822.

Organization: Health Canada

278 page(s)
September 2024

Req # A-2023-001333

Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_06719295, E2B_06758044. ADR for Pantoloc. Report number: 001066050. ADRs for Pantoprazole sodium. Report numbers: E2B_06731244, E2B_06741613. ADRs for Tecta. Report numbers:…

Organization: Health Canada

1885 page(s)
September 2024

Req # A-2023-001497

Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_06824978, E2B_06818170, E2B_06781412, E2B_06818361, E2B_06766936, E2B_06810905, E2B_06813780, E2B_06809546, E2B_06829661, E2B_06818363.

Organization: Health Canada

988 page(s)
September 2024

Req # A-2023-001533

Adverse Drug Reactions (ADRs). Report numbers: E2B_06779032, E2B_06779961, E2B_06779926, 001072788, E2B_06806126, E2B_06410273, 001068894, 001067286, E2B_06822633.

Organization: Health Canada

1617 page(s)
September 2024

Req # A-2024-000128

Adverse Drug Reactions (ADRs) for Morphine. Report numbers: 001075170, E2B_06906193. ADRs for Hydromorphone. Report numbers: 001075282, 001075286, 001075300, 001075304, 001075301, 001075303, 001075648. ADRs for Heparin. Report numbers: 001076801,…

Organization: Health Canada

168 page(s)
September 2024

Req # A-2024-000146

Adverse Drug Reactions (ADRs). Report numbers: E2B_07024147, 001086222, 001079010, 001078146, 001078143.

Organization: Health Canada

41 page(s)
September 2024

Req # A-2024-000175

Adverse Drug Reaction (ADR). Report number: E2B_06517909.

Organization: Health Canada

9 page(s)
September 2024
Date modified: